Effects and effectiveness of heparin in assisted reproduction

Journal of Reproductive Immunology

Volumn 90, Issue 1, 2011, Pages 82-90

  Bohlmann, Michael K ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Assisted reproduction; Heparin; Implantation failure; Thrombophilia; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; REPRODUCTION; THROMBOEMBOLISM; THROMBOPHILIA;

EMBRYO IMPLANTATION; FEMALE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

EID: 79959977652     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.03.004     Document Type: Article

References (57)

1. Aboulghar M. Treatment of ovarian hyperstimulation syndrome. Semin. Reprod. Med. 2010, 28:532-539.
2. Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest 2008, 133:844S-886S.
3. Bauersachs R.M., Manolopoulos K., Hoppe I., Arin M.J., Schleussner E. More on: the 'ART' behind the clot: solving the mystery. J. Thromb. Haemost. 2007, 5:438-439.
4. Bauersachs R.M., Dudenhausen J., Faridi A., Fischer T., Fung S., Geisen U., Harenberg J., Herchenhan E., Keller F., Kemkes-Matthes B., Schinzel H., Spannagl M., Thaler C.J. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb. Haemost. 2007, 98:1237-1245.
5. Bellver J., Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil. Steril. 2009, 92:1803-1810.
6. Bick R.L., Frenkel E.P., Walenga J., Fareed J., Hoppensteadt D.A. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. Hematol. Oncol. Clin. North. Am. 2005, 19:1-51.
7. Bohlmann M.K., Schauf B., Luedders D.W., Wallwiener D., Strowitzki T., von Wolff M. Current concepts of efficient diagnosis and therapeutic options in patients with recurrent early abortions. Geburtsh. Frauenheilk. 2007, 67:217-227.
8. Bohlmann M.K., Hornemann A., Ortmann J., Thill M., Diedrich K., Luedders D.W. Anticoagulation and assisted reproduction, improved pregnancy and birth rates through additional therapy with aspirin and heparin?. Gynäkol. Endokrinol. 2009, 7:74-79.
9. Centers for Disease Control and Prevention (CDC) Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996. MMWR Morb. Mortal. Wkly. Rep. 1998, 47:368-371.
10. Chan W.S., Ginsberg J.S. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J. Thromb. Haemost. 2006, 4:1673-1677.
11. Clark P., Brennand J., Conkie J.A., McCall F., Greer I.A., Walker I.D. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb. Haemost. 1998, 79:1166-1170.
12. Clark P., Walker I.D., Langhorne P., Crichton L., Thomson A., Greaves M., Whyte S., Greer I.A. SPIN: the Scottish Pregnancy Intervention Study: a multicentre randomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage. Blood 2010, 115:4162-4167.
13. Dobson A.T., Davis R.M., Rosen M.P., Shen S., Rinaudo P.F., Chan J., Cedars M.I. Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF. Hum. Reprod. 2007, 22:450-456.
14. d'Souza S.S., Daikoku T., Farach-Carson M.C., Carson D.D. Heparanase expression and function during early pregnancy in mice. Biol. Reprod. 2007, 77:433-441.
15. Fluhr H., Spratte J., Ehrhardt J., Steinmüller F., Licht P., Zygmunt M. Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells. Fertil. Steril. 2010, 93:2581-2587.
16. German IVF Register, 2009. DIR Annual Report 2009. Available from: http://www.deutsches-ivf-register.de/pdf-downloads/dirjahrbuch2009-e.pdf.
17. German Society for Gynaecology and Obstetrics, 2010. Guidelines. Available from: http://www.dggg.de/fileadmin/public_docs/Dokumente/Leitlinien/1-7-1-thrombembolie-2009-langfassung.pdf.
18. Halbmayer H.M., Feichtinger W., Kindermann C., Prendinger B., Böhm M. Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hämostaseologie 2005, 25:391-393.
19. Harris E.N., Hughes G.R. Thrombosis and miscarriages: the antiphospholipid antibody story. Atlas of Science: Immunology 1988, Institute of Scientific Information, Philadelphia, PA, pp. 155-160.
20. Hofer S., Heindl B., Meister F.C., Maul H., Martin E., Sohn C., Weigand M.A. Blutungen während Schwangerschaft und Geburt. Gynäkologe 2009, 42:55-69.
21. Ivanov P., Komsa-Penkova R., Kovacheva K., Konova E., Todorova K., Simeonova M., Ivanov I., Stoǐkov S., Popov I., Tanchev S., Bozhinova S. Risk of thrombophilia in carriers of thrombophilic genetic factors in unsuccessful assisted reproduction. Akush Ginekol. (Sofiia) 2007, 46:3-8.
22. Kaandorp S., Di Nisio M., Goddijn M., Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst. Rev. 2009, 1. CD004734.
23. Kaandorp S.P., Goddijn M., van der Post J.A., Hutten B.A., Verhoeve H.R., Hamulyák K., Mol B.W., Folkeringa N., Nahuis M., Papatsonis D.N., Büller H.R., van der Veen F., Middeldorp S. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N. Engl. J. Med. 2010, 362:1586-1596.
24. Kumar V., Hassan M.I., Tomar A.K., Kashav T., Nautiyal J., Singh S., Singh T.P., Yadav S. Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards identification of molecular markers of male fertility. J. Biosci. 2009, 34:899-908.
25. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., Fait G., Lessing J.B. Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 1999, 340:9-13.
26. Kutteh W.H., Yetman D.L., Chantilis S.J., Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum. Reprod. 1997, 12:1171-1175.
27. Laskin C.A., Spitzer K.A., Clark C.A., Crowther M.R., Ginsberg J.S., Hawker G.A., Kingdom J.C., Barrett J., Gent M. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J. Rheumatol. 2009, 36:279-287.
28. Lindqvist P., Dahlbäck B., Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet. Gynecol. 1999, 94:595-599.
29. Luedders D.W., Bundschuh D., Hornemann A., Hoerster J.C., Boemicke P., Köster F., Bohlmann M.K. Heparanase expression in term placentas of diabetic patients and healthy controls. Arch. Gynecol. Obstet. 2010, 10.1007/s00404-010-1636-5.
30. Luong T.H., Rand J.H., Wu X.X., Godbold J.H., Gascon-Lema M., Tuhrim S. Seasonal distribution of antiphospholipid antibodies. Stroke 2001, 32:1707-1711.
31. Lwaleed B.A., Greenfield R., Stewart A., Birch B., Cooper A.J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb. Haemost. 2004, 92:752-766.
32. Mancini A., Milardi D., di Pietro M.L., Giacchi E., Spagnolo A.G., di Donna V., de Marinis L., Jensen L. A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer. Fertil. Steril. 2001, 76:198-200.
33. Mantha S., Bauer K.A., Zwicker J.I. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J. Thromb. Haemost. 2010, 8:263-268.
34. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H., de Groot P.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006, 4:295-306.
35. Nadir Y., Henig I., Naroditzky I., Paz B., Vlodavsky I., Brenner B. Involvement of heparanase in early pregnancy losses. Thromb. Res. 2010, 125:e251-e257.
36. Nelson S.M., Greer I.A. The potential role of heparin in assisted conception. Hum. Reprod. Update. 2008, 14:623-645.
37. Nelson S.M., Greer I.A. Reply to Heparin's 'potential to improve pregnancy rates and outcomes' is not evidence-based. Hum. Reprod. Update. 2010, 16:227-228.
38. Pettilä V., Kaaja R., Leinonen P., Ekblad U., Kataja M., Ikkala E. Thrombophylaxis with low-molecular weight heparin (Dalteparin) in pregnancy. Thromb. Res. 1999, 96:275-282.
39. Prakash A., Ola B. Heparin/aspirin therapy for implantation failure in IVF cycles. Fertil. Steril. 2004, 81:1431.
40. Qublan H.S., Eid S.S., Ababneh H.A., Amarin Z.O., Smadi A.Z., Al-Khafaji F.F., Khader Y.S. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum. Reprod. 2006, 21:2694-2698.
41. Qublan H., Amarin Z., Dabbas M., Farraj A.E., Beni-Merei Z., Al-Akash H., Bdoor A.N., Nawasreh M., Malkawi S., Diab F., Al-Ahmad N., Balawneh M., Abu-Salim A. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum. Fertil. (Camb.) 2008, 11:246-253.
42. Rao A.K., Chitkara U., Milki A.A. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Hum. Reprod. 2005, 20:3307-3312.
43. Rey E., Kahn S.R., David M., Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003, 361:901-908.
44. Ricci G., Giolo E., Simeone R. 'Heparin's potential to improve pregnancy rates and outcomes' is not evidence based. Hum. Reprod. Update 2010, 16:225-227.
45. Rogolino A., Coccia M.E., Fedi S., Gori A.M., Cellai A.P., Scarselli G.F., Prisco D., Abbate R. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul. Fibrinolysis. 2003, 14:277-282.
46. Schenk L.M., Butler L., Morris J.P., Cox B., Lecte J., Abuhamed A., Ochninger S., Toner J.P., Muasher S. Heparin and aspiring treatment yield higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. Am. Soc. Reprod. Med. 1996, Abstract O-076.
47. Sharif K.W., Ghunaim S. Management of 273 cases of recurrent implantation failure: results of a combined evidence-based protocol. Reprod. BioMed. Online 2010, 21:373-380.
48. Sher G., Feinman M., Zouves C., Kuttner G., Maassarani G., Salem R., Matzner W., Ching W., Chong P. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod. 1994, 9:2278-2283.
49. Sher G., Matzner W., Feinman M., Maassarani G., Zouves C., Chong P., Ching W. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am. J. Reprod. Immunol. 1998, 40:74-82.
50. Simur A., Ozdemir S., Acar H., Colakoĝlu M.C., Görkemli H., Balci{dotless} O., Nergis S. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol. Obstet. Invest. 2008, 67:109-112.
51. Stern C., Chamley L., Norris H., Hale L., Baker H.W. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil. Steril. 2003, 80:376-383.
52. The Practice Committee of the American Society for Reproductive Medicine Anti-phospholipid antibodies do not affect IVF success. Fertil. Steril. 2008, 90(Suppl. 3):S172-S173.
53. The Practice Committee of the American Society for Reproductive Medicine Ovarian hyperstimulation syndrome. Fertil. Steril. 2008, 90(Suppl. 3):S188-S193.
54. Udoff L.C., Branch D.W. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J. Autoimmun. 2000, 15:209-211.
55. Urman B., Ata B., Yakin K., Alatas C., Aksoy S., Mercan R., Balaban B. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum. Reprod. 2009, 24:1640-1647.
56. von Wolff M., Rösner S., Thöne C., Pinheiro R.M., Jauckus J., Bruckner T., Biolchi V., Alia A., Strowitzki T. Intravaginal and intracervical application of seminal plasma in in vitro fertilization or intracytoplasmic sperm injection treatment cycles: a double-blind, placebo-controlled, randomized pilot study. Fertil. Steril. 2009, 91:167-172.
57. Yinon Y., Pauzner R., Dulitzky M., Elizur S.E., Dor J., Shulman A. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod. Biomed. Online 2006, 12:354-358.